Clinical Efficacy of House Dust Mite-specific Immunotherapy in Asthmatic Children

Pediatrics and Neonatology

Volumn 51, Issue 1, 2010, Pages 14-18

  Tsai, Tzu Chun ^a   Lu, Jen Her ^a   Chen, Shu Jen ^a   Tang, Ren Bin ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

asthma; children; house dust mite; immunotherapy

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HOUSE DUST ALLERGEN; LEUKOTRIENE RECEPTOR AFFECTING AGENT; PREDNISOLONE; THEOPHYLLINE;

ALLERGIC ASTHMA; ARTICLE; CHILD; CHILD HOSPITALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG USE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SERVICE; HUMAN; IMMUNOTHERAPY; INJECTION SITE SWELLING; LOW DRUG DOSE; MAINTENANCE THERAPY; MALE; MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM;

ADOLESCENT; ANIMALS; ASTHMA; CHILD; CHILD, PRESCHOOL; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE;

EID: 76749121510     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1875-9572(10)60004-6     Document Type: Article

References (32)

1. Noon L. Prophylactic inoculation against hay fever. Lancet 1 (1911) 1572-1573
2. Cooke R.A. Hay fever and asthma: the uses and limitation of desensitization. N Y Med J 107 (1918) 577-583
3. Inal A., Altintas D.U., Yilmaz M., Karakoc G.B., Kendirli S.G., and Sertdemir Y. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. J Investig Allergol Clin Immunol 17 (2007) 85-91
4. Malling H.J., and Weeke B. Position paper: immunotherapy. Allergy 48 (1993) S7-35
5. Bousquet J., and Michel F.B. Specific immunotherapy in asthma: is it effective?. J Allergy Clin Immunol 94 (1994) 1-11
6. Abramson M.J., Puy R.M., and Weiner J.M. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 151 (1995) 969-974
7. Adkinson Jr. N.F., Eggleston P.A., Eney D., et al. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 336 (1997) 324-331
8. Berg T., Nordvall L., and Lanner A. Clinical studies of a purified timothy pollen extract. Desensitization therapy with a purified timothy pollen preparation compared to a crude timothy pollen extract. I. Results of tests in vivo. Int Arch Allergy Appl Immunol 63 (1980) 266-274
9. Bosquet J., Becker W.M., Hejjaoni A., et al. Differences in clinical and immunologic reactivities of patients allergic to grass pollen and multiple pollen species. II. Efficacy of a double-blind placebo controlled specific immunotherapy with standardized extracts. J Allergy Clin Immunol 88 (1991) 43-53
10. Negrini A.C. Immunotherapy for respiratory allergic diseases: indications, efficacy and monitoring. Allergy Immunol 25 (1993) 431-435
11. Global Initiative for Asthma(GINA). GINA report, global strategy for asthma management and prevention (2004), National Institutes of Health, Bethesda, MD NIH publication 02-3659.
12. Voorhost R., Spieksma-Boezeman M., and Spieksma F.T.M. Is a mite (Dermatophagoides sp) the producer of the house dust allergen?. Allerg Asthma (Leipz) 6 (1964) 329-334 [In German]
13. Tang R.B., Tsai L.C., Hwang H.M., et al. The prevalence of allergic disease and IgE antibodies to house dust mite in school children in Taiwan. Clin Exp Allergy 20 (1990) 33-38
14. Tang R.B., and Wu K.K. Total serum IgE, allergy skin testing, and the radioallergosorbent test for the diagnosis of allergy in asthmatic children. Ann Allergy 64 (1989) 432-435
15. Hejjaoui A., Dhivert H., Michel F.B., and Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol 85 (1990) 473-479
16. Alvarez-Cuesta E., Bousquet J., Canonica G.W., Durham S.R., Malling H.J., and Valovirta E. Standards for practical allergen-specific immunotherapy. Allergy 61 Suppl 82 (2006) 1-20
17. Steen N., Hutchinson A., McColl E., et al. Development of a symptom based outcome measure for asthma. BMJ 309 (1994) 1065-1068
18. Di Bernardino C., Di Bernardino F., Colombo R., and Angrisano A. A case control study of Dermatophagoides immunotherapy in children below 5 years of age. Allerg Immunol (Paris) 34 (2002) 56-59
19. British Society for Allergy and Clinical Immunology (BSACI) Working Party. Position paper on allergen immunotherapy. Report of a BSACI working party. Clin Exp Allergy 23 Suppl 3 (1993) 1-44
20. Bousquet J., Lockey R., and Malling H.J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 102 (1998) 558-562
21. Tsai L.C., Tang R.B., Hung M.W., Chen H.M., and Tsai S.J. Expression of serum IL-2, IL2R, and CD8 levels during hyposensitization in house-dust-sensitive asthmatics. J Asthma 27 (1990) 307-314
22. Tsai L.C., Tang R.B., Hung M.W., and Chang Z.N. Changes in the levels of house dust mite specific IgG4 during immuno-therapy in asthmatic children. Clin Exp Allergy 21 (1991) 367-372
23. Tsai L.C., Hung M.W., and Tang R.B. Changes of serum-specific IgE antibody titer during hyposensitization in mite-sensitive asthmatic children. J Asthma 27 (1990) 95-100
24. Creticos P.S. The consideration of immunotherapy in the treatment of allergic asthma. J Allergy Clin Immunol 105 (2000) S559-S574
25. Peat J.K., Woolcock A.J., and Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 70 (1987) 171-179
26. Ulrik C.S., Backer V., and Dirksen A. A 10-year follow-up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 47 (1992) 14-18
27. Pifferi M., Baldini G., Marrazzini G., et al. Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study. Allergy 57 (2002) 785-790
28. Wahn U. Immunotherapy in children. Curr Opin Allergy Clin Immunol 2 (2002) 557-560
29. Nelson H.S. Efficacy and safety of allergen immunotherapy in children. Ann Allergy Asthma Immunol 96 (2006) S2-S5
30. Jacobsen L., Niggemann B., Dreborg S., et al. (The PAT investigator group). Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62 (2007) 943-948
31. Passalacqua G., and Durham S.R. Global Allergy and Asthma European Network. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 119 (2007) 881-891
32. Winther L., Malling H.J., and Mosbech H. Allergen-specific immunotherapy in birch-and grass-pollen-allergic rhinitis. II. Side-effects. Allergy 55 (2000) 827-835